110 related articles for article (PubMed ID: 3569167)
1. Respiratory failure following anti-lung serum: study on mechanisms associated with surfactant system damage.
Lachmann B; Hallman M; Bergmann KC
Exp Lung Res; 1987; 12(2):163-80. PubMed ID: 3569167
[TBL] [Abstract][Full Text] [Related]
2. Surfactant abnormality after endotoxin-induced lung injury in guinea-pigs.
Tahvanainen J; Hallman M
Eur J Respir Dis; 1987 Oct; 71(4):250-8. PubMed ID: 3319662
[TBL] [Abstract][Full Text] [Related]
3. Endobronchial surface active phospholipids in various pulmonary diseases.
Hallman M; Arjomaa P; Tahvanainen J; Lachmann B; Spragg R
Eur J Respir Dis Suppl; 1985; 142():37-47. PubMed ID: 3860395
[TBL] [Abstract][Full Text] [Related]
4. Interaction of transferrin saturated with iron with lung surfactant in respiratory failure.
Hallman M; Sarnesto A; Bry K
J Appl Physiol (1985); 1994 Aug; 77(2):757-66. PubMed ID: 8002525
[TBL] [Abstract][Full Text] [Related]
5. Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure.
Pison U; Obertacke U; Brand M; Seeger W; Joka T; Bruch J; Schmit-Neuerburg KP
J Trauma; 1990 Jan; 30(1):19-26. PubMed ID: 2296063
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary surfactant composition early in development of acute lung injury after cardiopulmonary bypass: prophylactic use of surfactant therapy.
Haslam PL; Baker CS; Hughes DA; MacNaughton PD; Moat NE; Dewar A; Aggarwal A; Evans TW
Int J Exp Pathol; 1997 Aug; 78(4):277-89. PubMed ID: 9505939
[TBL] [Abstract][Full Text] [Related]
7. Lung surfactant phospholipids in the foetus, newborn, and in the adult; evidence of abnormality in respiratory failure.
Hallman M
Ann Chir Gynaecol Suppl; 1982; 196():19-23. PubMed ID: 6961877
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of surfactant dysfunction in early acute lung injury.
Kennedy M; Phelps D; Ingenito E
Exp Lung Res; 1997; 23(3):171-89. PubMed ID: 9184787
[TBL] [Abstract][Full Text] [Related]
9. Endotoxin induces respiratory failure and increases surfactant turnover and respiration independent of alveolocapillary injury in rats.
Davidson KG; Bersten AD; Barr HA; Dowling KD; Nicholas TE; Doyle IR
Am J Respir Crit Care Med; 2002 Jun; 165(11):1516-25. PubMed ID: 12045126
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A.
McCormack FX; King TE; Voelker DR; Robinson PC; Mason RJ
Am Rev Respir Dis; 1991 Jul; 144(1):160-6. PubMed ID: 2064123
[TBL] [Abstract][Full Text] [Related]
11. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol.
Hallman M; Spragg R; Harrell JH; Moser KM; Gluck L
J Clin Invest; 1982 Sep; 70(3):673-83. PubMed ID: 6896715
[TBL] [Abstract][Full Text] [Related]
12. The proteins of human lung surfactant.
Postle AD; Hunt AN; Normand IC
Biochim Biophys Acta; 1985 Dec; 837(3):305-13. PubMed ID: 3840698
[TBL] [Abstract][Full Text] [Related]
13. [Experimental study on the treatment of smoke inhalation injury with lung lavage and exogenous pulmonary surfactant].
Xie E; Yang Z; Li A
Zhonghua Wai Ke Za Zhi; 1997 Dec; 35(12):745-8. PubMed ID: 10677998
[TBL] [Abstract][Full Text] [Related]
14. Exogenous surfactant preserves lung function and reduces alveolar Evans blue dye influx in a rat model of ventilation-induced lung injury.
Verbrugge SJ; Vazquez de Anda G; Gommers D; Neggers SJ; Sorm V; Böhm SH; Lachmann B
Anesthesiology; 1998 Aug; 89(2):467-74. PubMed ID: 9710406
[TBL] [Abstract][Full Text] [Related]
15. Aerosolized surfactant in lung-lavaged adult rats: factors influencing the therapeutic response.
Bahlmann H; Sun B; Nilsson G; Curstedt T; Robertson B
Acta Anaesthesiol Scand; 2000 May; 44(5):612-22. PubMed ID: 10786751
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of exogenous surfactant in experimental respiratory failure induced by hyperoxia.
Ennema JJ; Kobayashi T; Robertson B; Curstedt T
Acta Anaesthesiol Scand; 1988 Nov; 32(8):665-71. PubMed ID: 3213391
[TBL] [Abstract][Full Text] [Related]
17. Anti-IL-8 antibody potentiates the effect of exogenous surfactant in respiratory failure caused by meconium aspiration.
Mikolka P; Kopincova J; Kosutova P; Kolomaznik M; Calkovska A; Mokra D
Exp Lung Res; 2018 Feb; 44(1):40-50. PubMed ID: 29324051
[TBL] [Abstract][Full Text] [Related]
18. Experimental neonatal respiratory failure induced by lysophosphatidylcholine: effect of surfactant treatment.
Grossmann G; Tashiro K; Kobayashi T; Suzuki Y; Matsumoto Y; Waseda Y; Akino T; Curstedt T; Robertson B
J Appl Physiol (1985); 1999 Feb; 86(2):633-40. PubMed ID: 9931201
[TBL] [Abstract][Full Text] [Related]
19. Integrity of the alveolar-capillary barrier and alveolar surfactant system in smokers.
Schmekel B; Bos JA; Khan AR; Wohlfart B; Lachmann B; Wollmer P
Thorax; 1992 Aug; 47(8):603-8. PubMed ID: 1412116
[TBL] [Abstract][Full Text] [Related]
20. Biophysical activity of synthetic phospholipids combined with purified lung surfactant 6000 dalton apoprotein.
Notter RH; Shapiro DL; Ohning B; Whitsett JA
Chem Phys Lipids; 1987 Jun; 44(1):1-17. PubMed ID: 3607971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
